Neuspera Medical Announces Final Close of $26M Series B Equity Financing
Summary
Neuspera Medical completed the final close of its $26 million Series B round with a $12 million second tranche. The company tied this tranche to predefined product development and regulatory milestones, showing progress in its program execution. It plans to use the capital to advance clinical work for its implantable neuromodulation technology platform. The news signals continued investor support for a clinical-stage medical device company focused on miniaturized implantable systems.
Funding
Amount
$26.0M
Total raised
Date
February 20, 2019
Announcement date
Investors
Windham Venture Partners, Action Potential Venture Capital, Delta Capital, 6 Dimensions Capital
Lead investors
Company
neuspera.com
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected